Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein

Abstract

Hepatitis B virus (HBV) is regarded as a stealth virus, invading and replicating efficiently in human liver undetected by host innate antiviral immunity. Here, we show that type I interferon (IFN) induction but not its downstream signaling is blocked by HBV replication in HepG2.2.15 cells. This effect may be partially due to HBV X protein (HBx), which impairs IFNβ promoter activation by both Sendai virus (SeV) and components implicated in signaling by viral sensors. As a deubiquitinating enzyme (DUB), HBx cleaves Lys63-linked polyubiquitin chains from many proteins except TANK-binding kinase 1 (TBK1). It binds and deconjugates retinoic acid-inducible gene I (RIG I) and TNF receptor-associated factor 3 (TRAF3), causing their dissociation from the downstream adaptor CARDIF or TBK1 kinase. In addition to RIG I and TRAF3, HBx also interacts with CARDIF, TRIF, NEMO, TBK1, inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon (IKKi) and interferon regulatory factor 3 (IRF3). Our data indicate that multiple points of signaling pathways can be targeted by HBx to negatively regulate production of type I IFN.

Keywords

hepatitis B virus (HBV) / HBV X protein (HBx) / deubiquitination / type I interferon

References

[1] Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801 .16497588
[2] Bhoj, V.G., and Chen, Z.J. (2009). Ubiquitylation in innate and adaptive immunity. Nature 458, 430-437 .1932562210.1038/nature07959
[3] Bouchard, M.J., and Schneider, R.J. (2004). The enigmatic X gene of hepatitis B virus. J Virol 78, 12725-12734 .1554262510.1128/JVI.78.23.12725-12734.2004
[4] Bowie, A.G., and Unterholzner, L. (2008). Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 8, 911-922 .1898931710.1038/nri2436
[5] Christen, V., Duong, F., Bernsmeier, C., Sun, D., Nassal, M., and Heim, M.H. (2007). Inhibition of alpha interferon signaling by hepatitis B virus. J Virol 81, 159-165 .1706520810.1128/JVI.01292-06
[6] Dienstag, J.L. (2008). Hepatitis B virus infection. N Engl J Med 359, 1486-1500 .1883224710.1056/NEJMra0801644
[7] Dunn, C., Peppa, D., Khanna, P., Nebbia, G., Jones, M., Brendish, N., Lascar, R.M., Brown, D., Gilson, R.J., Tedder, R.J., (2009). Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137, 1289-1300 .1959183110.1053/j.gastro.2009.06.054
[8] Fernández, M., Quiroga, J.A., and Carre?o, V. (2003). Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins. J Gen Virol 84, 2073-2082 .1286763710.1099/vir.0.18966-0
[9] Fisicaro, P., Valdatta, C., Boni, C., Massari, M., Mori, C., Zerbini, A., Orlandini, A., Sacchelli, L., Missale, G., and Ferrari, C. (2009). Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58, 974-982 .19201769
[10] Friedman, C.S., O’Donnell, M.A., Legarda-Addison, D., Ng, A., Cárdenas, W.B., Yount, J.S., Moran, T.M., Basler, C.F., Komuro, A., Horvath, C.M., (2008). The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep 9, 930-936 .1863608610.1038/embor.2008.136
[11] Gack, M.U., Shin, Y.C., Joo, C.H., Urano, T., Liang, C., Sun, L., Takeuchi, O., Akira, S., Chen, Z., Inoue, S., (2007). TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920 .1739279010.1038/nature05732
[12] Gao, D., Yang, Y.K., Wang, R.P., Zhou, X., Diao, F.C., Li, M.D., Zhai, Z.H., Jiang, Z.F., and Chen, D.Y. (2009). REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS One 4, e5760.1948412310.1371/journal.pone.0005760
[13] Guo, B., and Cheng, G. (2007). Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J Biol Chem 282, 11817-11826 .1732722010.1074/jbc.M700017200
[14] Guy, C.S., Mulrooney-Cousins, P.M., Churchill, N.D., and Michalak, T.I. (2008). Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J Virol 82, 8579-8591 .18596101
[15] Hochstrasser, M. (2009). Origin and function of ubiquitin-like proteins. Nature 458, 422-429 .1932562110.1038/nature07958
[16] Honda, K., Takaoka, A., and Taniguchi, T. (2006). Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25, 349-360 .1697956710.1016/j.immuni.2006.08.009
[17] Kawagoe, T., Takeuchi, O., Takabatake, Y., Kato, H., Isaka, Y., Tsujimura, T., and Akira, S. (2009). TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. Nat Immunol 10, 965-972 .1966822110.1038/ni.1771
[18] Kawai, T., Sato, S., Ishii, K.J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K., Matsuda, M., Inoue, J., Uematsu, S., (2004). Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5, 1061-1068 .1536186810.1038/ni1118
[19] Kayagaki, N., Phung, Q., Chan, S., Chaudhari, R., Quan, C., O’Rourke, K.M., Eby, M., Pietras, E., Cheng, G., Bazan, J.F., (2007). DUBA: a deubiquitinase that regulates type I interferon production. Science 318, 1628-1632 .1799182910.1126/science.1145918
[20] Li, K., Chen, Z., Kato, N., Gale, M. Jr, and Lemon, S.M. (2005). Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem 280, 16739-16747 .1573799310.1074/jbc.M414139200
[21] Lok, A.S., and McMahon, B.J. (2007). Chronic hepatitis B. Hepatology 45, 507-539 .1725671810.1002/hep.21513
[22] McCartney, S.A., and Colonna, M. (2009). Viral sensors: diversity in pathogen recognition. Immunol Rev 227, 87-94 .1912047810.1111/j.1600-065X.2008.00726.x
[23] Medzhitov, R. (2007). Recognition of microorganisms and activation of the immune response. Nature 449, 819-826 .1794311810.1038/nature06246
[24] Melegari, M., Scaglioni, P.P., and Wands, J.R. (1998). Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol 72, 1737-1743 .9499022
[25] O’Neill, L.A. (2009). DNA makes RNA makes innate immunity. Cell 138, 428-430 .19665965
[26] Oshiumi, H., Matsumoto, M., Hatakeyama, S., and Seya, T. (2009). Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. J Biol Chem 284, 807-817 .1901763110.1074/jbc.M804259200
[27] Pang, R., Lee, T.K., Poon, R.T., Fan, S.T., Wong, K.B., Kwong, Y.L., and Tse, E. (2007). Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology 132, 1088-1103 .1738343010.1053/j.gastro.2006.12.030
[28] Randall, R.E., and Goodbourn, S. (2008). Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89, 1-47 .1808972710.1099/vir.0.83391-0
[29] Randow, F., and Lehner, P.J. (2009). Viral avoidance and exploitation of the ubiquitin system. Nat Cell Biol 11, 527-534 .1940433210.1038/ncb0509-527
[30] Reyes-Turcu, F.E., Ventii, K.H., and Wilkinson, K.D. (2009). Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem 78, 363-397 .1948972410.1146/annurev.biochem.78.082307.091526
[31] Sabbah, A., Chang, T.H., Harnack, R., Frohlich, V., Tominaga, K., Dube, P.H., Xiang, Y., and Bose, S. (2009). Activation of innate immune antiviral responses by Nod2. Nat Immunol 10, 1073-1080 .1970118910.1038/ni.1782
[32] Saitoh, T., Tun-Kyi, A., Ryo, A., Yamamoto, M., Finn, G., Fujita, T., Akira, S., Yamamoto, N., Lu, K.P., and Yamaoka, S. (2006). Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol 7, 598-605 .1669952510.1038/ni1347
[33] Schroder, K., Muruve, D.A., and Tschopp, J. (2009). Innate immunity: cytoplasmic DNA sensing by the AIM2 inflammasome. Curr Biol 19, R262-R265 .1932114610.1016/j.cub.2009.02.011
[34] Tang, H., Delgermaa, L., Huang, F., Oishi, N., Liu, L., He, F., Zhao, L., and Murakami, S. (2005). The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol 79, 5548-5556 .1582716910.1128/JVI.79.9.5548-5556.2005
[35] Tenoever, B.R., Ng, S.L., Chua, M.A., McWhirter, S.M., García-Sastre, A., and Maniatis, T. (2007). Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315, 1274-1278 .1733241310.1126/science.1136567
[36] Wang, C., Chen, T., Zhang, J., Yang, M., Li, N., Xu, X., and Cao, X. (2009). The E3 ubiquitin ligase Nrdp1 ‘preferentially’ promotes TLR-mediated production of type I interferon. Nat Immunol 10, 744-752 .1948371810.1038/ni.1742
[37] Wang, H., and Ryu, W.S. (2010). Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog 6, e1000986.2065782210.1371/journal.ppat.1000986
[38] Wang, X., Li, Y., Mao, A., Li, C., Li, Y., and Tien, P. (2010). Hepatitis B virus X protein suppresses virus-triggered IRF3 activation and IFN-beta induction by disrupting the VISA-associated complex. Cell Mol Immunol 7, 341-348 .2071123010.1038/cmi.2010.36
[39] Weber, S., Maass, F., Schuemann, M., Krause, E., Suske, G., and Bauer, U.M. (2009). PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling. Genes Dev 23, 118-132 .1913662910.1101/gad.489409
[40] Webster, G.J., Reignat, S., Maini, M.K., Whalley, S.A., Ogg, G.S., King, A., Brown, D., Amlot, P.L., Williams, R., Vergani, D., (2000). Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32, 1117-1124 .1105006410.1053/jhep.2000.19324
[41] Wei, C., Ni, C., Song, T., Liu, Y., Yang, X., Zheng, Z., Jia, Y., Yuan, Y., Guan, K., Xu, Y., (2010). The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J Immunol 185, 1158-1168 .2055496510.4049/jimmunol.0903874
[42] Whitten, T.M., Quets, A.T., and Schloemer, R.H. (1991). Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene. J Virol 65, 4699-4704 .1870197
[43] Wieland, S., Thimme, R., Purcell, R.H., and Chisari, F.V. (2004). Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 101, 6669-6674 .1510041210.1073/pnas.0401771101
[44] Wieland, S.F., and Chisari, F.V. (2005). Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79, 9369-9380 .1601490010.1128/JVI.79.15.9369-9380.2005
[45] Wu, J., Meng, Z., Jiang, M., Pei, R., Trippler, M., Broering, R., Bucchi, A., Sowa, J.P., Dittmer, U., Yang, D., (2009). Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 49, 1132-1140 .1914021910.1002/hep.22751
[46] Wu, M., Xu, Y., Lin, S., Zhang, X., Xiang, L., and Yuan, Z. (2007). Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1. J Gen Virol 88, 3260-3269 .1802489410.1099/vir.0.82959-0
[47] Zeng, W., Sun, L., Jiang, X., Chen, X., Hou, F., Adhikari, A., Xu, M., and Chen, Z.J. (2010). Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141, 315-330 .20403326
[48] Zeng, W., Xu, M., Liu, S., Sun, L., and Chen, Z.J. (2009). Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol Cell 36, 315-325 .1985413910.1016/j.molcel.2009.09.037
[49] Zhao, T., Yang, L., Sun, Q., Arguello, M., Ballard, D.W., Hiscott, J., and Lin, R. (2007). The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat Immunol 8, 592-600 .1746875810.1038/ni1465
[50] Zheng, D., Chen, G., Guo, B., Cheng, G., and Tang, H. (2008). PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production. Cell Res 18, 1105-1113 .18957937